Pricing updated 2019-06-26. Prices are subject to change without notice.
AP39 is a compound used to increase the levels of hydrogen sulfide (H2S) within mitochondria.1 It consists of a mitochondria-targeting motif (triphenylphosphonium) coupled to an H2S-donating moiety (dithiolethione) by an aliphatic linker. AP39 (30-300 nM) dose-dependently increases H2S levels in endothelial cells, predominantly in mitochondrial regions.1 It stimulates mitochondrial electron transport and improves cellular bioenergetic function at lower concentrations (30-100 nM), while having an inhibitory effect at 300 nM.1 Under oxidative stress conditions induced by glucose oxidase, AP39 has antioxidant and cytoprotective effects.1 AP39 is effective in vivo, inhibiting voltage-dependent T-type calcium channels and improving hemodynamic parameters in rats.2
Warning - this product is not for human or veterinary use.
View the Cayman Structure Database for chemical structure definitions for many Cayman products
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.
Szczesny, B., Módis, K., Yanagi, K., et al. AP39, a novel mitochondria-
2. Tomasova, L., Pavlovicova, M., Malekova, L., et al. Effects of AP39, a novel triphenylphosphonium derivatised anethole dithiolethione hydrogen sulfide donor, on rat haemodynamic parameters and chloride and calcium Cav3 and RyR2 channels Nitric Oxide: Biology and Chemistry 46, 131-144 (2015).